GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Astrazeneca Plc (AZN) [hlAlert]

Rating:
Overweight
AZN
down 8.74 %

Astrazeneca Plc (AZN) upgraded to Overweight by Morgan Stanley

Posted on: Tuesday,  Dec 1, 2015  12:25 PM ET by Morgan Stanley

Morgan Stanley rated Overweight Astrazeneca Plc (NYSE: AZN) on 12/01/2015, when the stock price was $34.64. Since
then, Astrazeneca Plc has lost 8.75% as of 01/19/2016's recent price of $31.61.
If you would have followed this Morgan Stanley's recommendation on AZN, you would have lost 8.74% of your investment in 49 days.

AstraZeneca PLC (AstraZeneca) is engaged in the discovery, development, manufacturing and marketing of prescription pharmaceuticals and biological products for important areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. The Company?s product portfolio comprise: Arimidex, Crestor, Nexium, Seroquel and Symbicort. It has operations in various markets, such as China, United Kingdom, Sweden and the United States. It has 26 manufacturing sites in 18 countries. Cardiovascular product pipeline includes Saxagliptin, Dapagliflozin, Atherosclerosis/dyslipidaemia, Thrombosis and Atrial fibrillation. Gastrointestinal pipeline includes life cycle management initiatives. AstraZeneca?s Infection pipeline MedImmune and Dedicated tuberculosis (TB) research. Oncology product pipeline includes Zactima (vandetanib), Zactima (vandetanib), ZD4054 and MedImmune.

Morgan Stanley Investment Research is one of the financial industry's dominant thought leaders in equity and fixed-income investing. Our analysts, economists, and strategists have earned this reputation through timely, in-depth analysis of companies, industries, markets, and the world’s economies. Our teams collaborate to assist Morgan Stanley clients with investment decisions, using cash and derivative instruments across major asset classes and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/1/2015 12:25 PM Buy
None
34.64
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/7/2012 8:25 AM Hold
None
23.37

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy